This case study addresses challenges and the opportunities faced by Danish pharmaceutical company Novo Nordisk with regard to its sustainability strategy in China as of 2012. Novo Nordisk is recognized for striving to integrate its business activities in a fiscally, environmentally, and socially responsible manner, and several Novo Nordisk staff proudly refers to the Novo Nordisk as a "triple bottom line (TBL) business."
Novo Nordisk Managing Sustainability at Home and Abroad Case Study Solution
Novo Nordisk has been active in China for greater than 50 years; nevertheless, since the Chinese market has grown enormously, a more sedentary Western lifestyle along with this increase in prosperity have led to growing difficulties with obesity. As a consequence, China's insulin market is booming. Novo Nordisk so faces new challenges concerning how best to arrange its TBL application in a sense that ensures a thorough strategy through the organization, yet permits Novo Nordisk China to adopt initiatives that fit the Chinese business context. Moreover, with ever-increasing competition for access to China's lucrative insulin market, the competitions of Novo Nordisk are also engaging in sustainability, which must use sustainability as a wellspring of competitive advantage, and hints that Novo Nordisk must keep innovating to distinguish itself.
PUBLICATION DATE: September 07, 2012 PRODUCT #: W12186-HCB-ENG
This is just an excerpt. This case is about STRATEGY & EXECUTION
Related Case Solutions & Analyses:
Laura Wollen and ARPCO Inc.
Gaston Acurio: A Recipe for Success
Luminar: Leveraging Big Data Using Corporate Entrepreneurship
Fuel Hedging At Jetblue Airways 2012
Truearth Healthy Foods: Market Research For A New Product Introduction
Fiji Water: Carbon Negative
Chevron Corporation: Corporate Image Advertising
CarMax: Disrupting the Used-Car Market
WM Wrigley JR. Company: Innovation in China’s Confectionery Market
The Invisible Green Hand: How Individual Decisions and Markets Can Reduce Greenhouse Gas Emissions
